Cross Immune Response Between Breast Carcinoma and Thyroid Autoimmunity: Impact on Prognosis and Treatment

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerPhase 2Recruiting

Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7

This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…

Mobile, United StatesEst. completion Nov 6, 2020

View Trial →

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic LymphomaPhase 2Recruiting

Lymphoplasmacytic LymphomaWaldenstrom Macroglobulinemia

This phase II trial studies the effects of venetoclax and rituximab in comparison to ibrutinib and rituximab or zanubrut…

Tucson, United StatesEst. completion Mar 31, 2028

View Trial →

Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP TrialPhase 3Recruiting

Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8

This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients …

Birmingham, United StatesEst. completion Dec 31, 2026

View Trial →

Cross Immune Response Between Breast Carcinoma and Thyroid Autoimmunity: Impact on Prognosis and Treatment

Trial Details

Other microbiome trials you might be interested in